Neurotrack is a digital health company on a mission to transform the diagnosis and management of dementia and Alzheimer's disease. Neurotrack has published 25 peer-reviewed papers, holds 11 patents on its proprietary technology, and is registered as an FDA Class II medical device. Its solutions have been recognized by leading organizations including the Cleveland Clinic. For more information visit neurotrack.com.